Search filters
Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 90
  • 14
  • 175
  • 704
  • 456
  • 14
  • 32
  • 1
  • 4
  • 655

Found 706 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

99 years or below
All genders
30.0
Learn More

UPCC 03621: A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B (Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

99 years or below
All genders
TBD
Learn More

EA5191 A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated NonSquamous NSCLC

99 years or below
All genders
TBD
Learn More

An Expanded Access Program for Efgartigimod Treatment in Patients With Generalized Myasthenia Gravis

99 years or below
All genders
1.0
Learn More

An open label single arm study of the safety pharmacokinetics and antiretroviral activity of the combination of 3BNC117-LS and 10-1074-LS in viremic HIV-infected individuals

99 years or below
All genders
TBD
Learn More

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)

99 years or below
All genders
TBD
Learn More

UPCC 02521 A Randomized Phase II Trial of Cabozantinib Combined with PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

99 years or below
All genders
Phase 2
0.0
Learn More

Randomized Controlled Trial of Budesonide + Surfactant

99 years or below
All genders
Phase 3
150.0
Learn More

Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-rResponders and Previously Intreable Patients

99 years or below
All genders
52.0
Learn More

UPCC 03120: Randomized Double-Blind Phase 3 Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T-DM1) for Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)

99 years or below
All genders
TBD
Learn More
311 - 320 of 706